HomeACIU • NASDAQ
AC Immune SA
Follow
In the news
Financials
Income Statement
Revenue
Net Income
Revenue
Net income
| (CHF) | Dec 2024info | Y/Y change |
|---|---|---|
Revenue | 1.14M | -92.32% |
Operating expense | 3.97M | 7.36% |
Net income | -15.80M | -232.99% |
Net profit margin | -1.39K | -4,234.98% |
Earnings per share | -0.16 | -220.00% |
EBITDA | -18.26M | -484.48% |
Effective tax rate | -0.02% | — |
Balance Sheet
Total Assets
Total Liabilities
Total assets
Total liabilities
| (CHF) | Dec 2024info | Y/Y change |
|---|---|---|
Cash and short-term investments | 165.49M | 60.59% |
Total assets | 230.91M | 26.31% |
Total liabilities | 118.64M | 435.13% |
Total equity | 112.27M | — |
Shares outstanding | 98.94M | — |
Price to book | 1.68 | — |
Return on assets | -19.59% | — |
Return on capital | -37.10% | — |
Cash Flow
Net Change in Cash
Net change in cash
| (CHF) | Dec 2024info | Y/Y change |
|---|---|---|
Net income | -15.80M | -232.99% |
Cash from operations | 5.93M | 136.65% |
Cash from investing | -3.83M | -116.43% |
Cash from financing | -197.00K | -100.48% |
Net change in cash | 3.86M | -91.72% |
Free cash flow | 12.46M | 184.29% |
Previous close
$1.88
Day range
$1.80 - $1.86
Year range
$1.77 - $4.98
Market cap
180.74M USD
Avg Volume
193.15K
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
About
Founded
2003
Website
Employees
153
